Operating Expenses Changement
Abbott ABT:US $ 8869M 114M
Abbvie ABBV:US $ 11288M 2467M
ALKERMES ALKS:US 310.68M 5.55M
Amgen AMGN:US $ 4.42B 680M
AstraZeneca AZN:LN 10.23B 280M
Astrazeneca AZN:US 10.23B 280M
Biogen BIIB:US $ 2648.2M 727.1M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Catalent CTLT:US $ 1.06B 6M
Coherus Biosciences CHRS:US $ 104.16M 43.1M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Endo International Ordinary Shares ENDP:US $ 583.27M 618.52M
Gilead Sciences GILD:US $ 4231M 2162M
GlaxoSmithKline GSK:LN 5.85B 1.13B
Horizon Pharma HZNP:US $ 787.85M 96.93M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Johnson & Johnson JNJ:US $ 18.18B 616M
Lannett LCI:US $ 100.44M 54.15M
Medtronic MDT:US $ 6418M 314M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Perrigo Ordinary Shares PRGO:US $ 1052.8M 5.4M
Pfizer PFE:US $ 15640M 148M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Revance Therapeutics RVNC:US $ 87.48M 72K
Teva Pharmaceutical Industries TEVA:US 4.74B 361M
United Therapeutics UTHR:US $ 265.1M 89.5M
Zoetis ZTS:US $ 1.38B 123M



Bristol-Myers Squibb Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2022.